Internal Medicine, Rheumatology · St Louis Park, MN
NPI
1881671881
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3800 Park Nicollet Blvd
St Louis Park, MN, 55416
Phone (952) 993-2808
Groups this clinician bills Medicare through
Medicare paid, 2024
$829K
50,695 services
Medicare patients, 2024
503
Average age 75
Drug cost, 2024
$2.1M
2,232 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tawatchai Paisansinsup was code J3262 (injection, tocilizumab, 1 mg), 9,600 times for 12 patients. In total Tawatchai Paisansinsup billed 50,695 services in 124 codes, and Medicare paid $829K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 9,600 | 12 | $4.70 | $45K |
| Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 2,960 | 28 | $23.05 | $68K |
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 20 | $20.18 | $28K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,362 | 23 | $0.10 | $133 |
| 36415 Venipuncture Blood Collection | Office | 348 | 150 | $8.55 | $2,976 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 331 | 11 | $0.21 | $71.11 |
| 85025 Blood Count | Office | 273 | 106 | $7.55 | $2,062 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 216 | 141 | $11.94 | $2,578 |
| 99214 Office E&M - Established | Office | 189 | 103 | $91.23 | $17K |
| 84460 Clinical Chemistry | Office | 165 | 70 | $5.13 | $846 |
| 99213 Office E&M - Established | Office | 158 | 114 | $56.74 | $8,965 |
| 82565 Clinical Chemistry | Office | 158 | 79 | $4.96 | $783 |
| 77092 Standard X-ray | Office | 133 | 133 | $6.37 | $847 |
| 96365 Intravenous Infusion, Hydration | Office | 131 | 74 | $48.47 | $6,350 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 117 | 24 | $5.14 | $601 |
By year: 2022 $857K for 46,006 services; 2023 $379K for 30,716 services; 2024 $829K for 50,695 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 348 | 150 | $8.55 | $2,976 |
| 85025 Blood Count | 273 | 106 | $7.55 | $2,062 |
| 84460 Clinical Chemistry | 165 | 70 | $5.13 | $846 |
| 82565 Clinical Chemistry | 158 | 79 | $4.96 | $783 |
| 85652 Clinical Chemistry | 103 | 36 | $2.65 | $273 |
| 86140 Clinical Chemistry | 70 | 28 | $5.08 | $356 |
| 82310 Clinical Chemistry | 32 | 26 | $5.06 | $162 |
| 81003 Clinical Chemistry | 25 | 16 | $2.20 | $55 |
Medicare prescription drug claims, 2024
In 2024, the drug Tawatchai Paisansinsup prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 683 prescriptions and refills. In total Tawatchai Paisansinsup wrote 2,232 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 683 | 1,799 | 186 | $21K |
| Prednisone Generic | 360 | 786 | 130 | $4,746 |
| Alendronate Sodium Generic | 147 | 398 | 51 | $1,962 |
| Leflunomide Generic | 141 | 414 | 42 | $15K |
| Humira(Cf) Pen Adalimumab | 122 | 122 | 13 | $837K |
| Hydroxychloroquine Sulfate Generic | 118 | 319 | 34 | $5,615 |
| Folic Acid Generic | 58 | 178 | 19 | $623 |
| Allopurinol Generic | 48 | 130 | 14 | $967 |
| Tramadol Hcl Generic | 39 | 40 | Under 11 | $275 |
| Enbrel Sureclick Etanercept | 37 | 39 | Under 11 | $289K |
| Gabapentin Generic | 37 | 87 | 12 | $717 |
| Enbrel Etanercept | 33 | 33 | Under 11 | $247K |
| Celecoxib Generic | 32 | 69 | Under 11 | $2,052 |
| Azathioprine Generic | 26 | 66 | Under 11 | $2,008 |
| Cyltezo(Cf) Pen Adalimumab-Adbm | 26 | 26 | Under 11 | $201K |
Brand drugs: - claims; generic drugs: 1,881 claims; opioid claims: 63.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Tawatchai Paisansinsup were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.